Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (28)
  • 2024 (23)
  • 2023 (28)
  • 2022 (46)
  • 2021 (77)
  • 2020 (59)
  • 2019 (54)
  • 2018 (78)
  • 2017 (108)
  • 2016 (58)
  • 2015 (29)
  • 2014 (34)
  • 2013 (49)
  • 2012 (9)
  • 2011 (38)

Subject

  • Drug Trafficking (71)
  • Prescription Drugs (38)
  • Fake Pills (29)
  • Guns/Weapons (29)
  • Take Back Day (29)
  • Arrests/Convictions - Major (27)
  • Outreach/Drug Prevention (26)
  • Synthetic drugs (24)
  • OCDETF/Task Force (17)
  • Pharmaceuticals/Pharmacists/Physicians (17)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Major Law Enforcement Operation (16)
  • Diversion Division (15)
  • One Pill Can Kill (14)
  • Overdose (14)
  • Press Conferences (14)
  • Congressional Affairs (12)
  • Guilty Plea (11)
  • Seizures (Drugs/Property) (11)
  • Fentanyl Awareness (10)
  • Money Laundering (10)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Red Ribbon (9)
  • Extraditions (8)
  • International/Foreign Operations (8)
  • Gangs (6)
  • Counterfeit Pills (4)
  • Fentanyl Free America (4)
  • Intergovernmental Affairs (4)
  • Narcoterrorism (4)
  • Task Forces/Task Force Officers (4)
  • Campaigns (3)
  • Critical Incident (3)
  • HIDTA (3)
  • Scam Calls (3)
  • Terrorism (2)
  • Dark Web- Internet Trafficking (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Fentanyl (83)
  • Methamphetamine (53)
  • Cocaine (48)
  • Heroin (27)
  • Marijuana (Cannabis) (11)
  • Opioids (10)
  • Oxycodone (10)
  • Synthetic Opioids (8)
  • Ecstasy/MDMA (2)
  • Marijuana Concentrates (2)
  • Steroids (2)
  • Amphetamines (1)
  • GHB (1)
  • Hydromorphone (1)
  • Ketamine (1)
  • Morphine (1)
  • Psilocybin (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (812)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Los Angeles (300)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Omaha (137)
  • Louisville (81)
  • Caribbean (79)
  • Caribbean (1)
  • Headquarters (414)
  • Dallas (315)
Clear All Results
723 Results - Showing 311 to 320
PRESS RELEASE

Orthopedic Surgeon Sentenced for Opioid Prescription Conspiracies

TULSA, Okla. – An orthopedic surgeon, who formerly practiced in Claremore, was sentenced today in U.S. District Court for leading multiple conspiracies to write fraudulent opioid prescriptions from October 2015 to October 2017, announced United States Drug Enforcement Administration Dallas Division Special Agent in Charge Clyde E. Shelley, Jr. and...
PRESS RELEASE

Eleven Muskogee defendants indicted in federal drug conspiracy

MUSKOGEE, Okla. – The United States Attorney’s Office for the Eastern District of Oklahoma announced that Muskogee residents Christopher Michael Whitaker Sr. aka “Unc”, 44; Devin Trevon Whitaker, 19; Torrell Dshaun Bogar aka “T Real”, 21; Aaron Oneal Bogar aka Aaron Oneal Wilson, aka “AB”, 19; Drew Alexander Ragsdale aka...
PRESS RELEASE

Twenty-two defendants sentenced in Fallen Kings drug conspiracy case

The final defendant in the Fallen Kings drug trafficking conspiracy case has been sentenced, announced DEA Dallas Division Special Agent in Charge Clyde E. Shelley, Jr., and U.S. Attorney for the Northern District of Texas Erin Nealy Cox. Defendants will spend between six months and more than 33 years in...
PRESS RELEASE

Dallas man pleads guilty in steroid scheme

A Dallas man pleaded guilty today to possessing steroids with the intent to distribute them, announced DEA Dallas Division Special Agent in Charge Clyde E. Shelley, Jr., and U.S. Attorney for the Northern District of Texas Erin Nealy Cox. Christopher Crotty, 34, is the second of two defendants to plead...
PRESS RELEASE

J-CODE announces 61 arrests in its second coordinated law enforcement operation targeting opioid trafficking on the Darknet

WASHINGTON – Today, members of the Joint Criminal Opioid and Darknet Enforcement team announce the results of Operation SaboTor, a coordinated international effort targeting drug trafficking organizations operating on the Darknet. This is J-CODE’s second coordinated action and follows the success of last year’s Operation Disarray . As a result...
PRESS RELEASE

DEA warns of alarming increase of scam calls

WASHINGTON – The Drug Enforcement Administration urges its DEA-registered practitioners and members of the public to be cautious of telephone calls from criminals posing as DEA or other law enforcement personnel threatening arrest and prosecution for supposed violations of federal drug laws or involvement in drug-trafficking activities. DEA continues to...
PRESS RELEASE

Shutdown of drug-infested hotel that bred violence and death

DALLAS – A U.S. District Judge has granted federal prosecutors’ motion to shut down a drug-infested hotel located just 1000 feet from a Dallas elementary school, DEA Dallas Division Special Agent in Charge Clyde E. Shelley, Jr., and U.S. Attorney Erin Nealy Cox announced today. On Thursday, a task force...
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
PRESS RELEASE

DEA showcases the dangers of drug addiction through travelling museum exhibit

ALBUQUERQUE, N.M. – DEA Acting Administrator Uttam Dhillon today unveiled the Drug Enforcement Administration’s 5,500 square foot Drugs: Costs and Consequences travelling exhibit in Albuquerque with a ribbon-cutting ceremony at the New Mexico Museum of Natural History and Science, where it will be housed for the next several months. The...
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...

Pagination

  • First page «
  • Previous
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Current page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster